Polyphenols and neuroprotection: Therapeutic implications for cognitive decline

G Caruso, SA Torrisi, MP Mogavero, W Currenti… - Pharmacology & …, 2022 - Elsevier
Dietary polyphenols have been the focus of major interest for their potential benefits on
human health. Several preclinical studies have been conducted to provide a rationale for …

[HTML][HTML] Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives

DJ Baker, RC Petersen - The Journal of clinical …, 2018 - Am Soc Clin Investig
Along with a general decline in overall health, most chronic degenerative human diseases
are inherently associated with increasing age. Age-associated cognitive impairments and …

Aging, inflammation and the environment

A Bektas, SH Schurman, R Sen, L Ferrucci - Experimental gerontology, 2018 - Elsevier
The aging process is driven by interrelated mechanisms that lead to the emergence of
characteristic phenotypes that include changes in body composition, energy production and …

[HTML][HTML] The potential of flavonoids for the treatment of neurodegenerative diseases

P Maher - International journal of molecular sciences, 2019 - mdpi.com
Neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD),
Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS), currently affect more …

Metformin improves learning and memory in the SAMP8 mouse model of Alzheimer's disease

SA Farr, E Roesler, ML Niehoff… - Journal of …, 2019 - content.iospress.com
Metformin is used for the treatment of insulin resistant diabetes. Diabetics are at an
increased risk of developing dementia. Recent epidemiological studies suggest that …

The neuroprotective effects of intermittent fasting on brain aging and neurodegenerative diseases via regulating mitochondrial function

Y Zhao, M Jia, W Chen, Z Liu - Free Radical Biology and Medicine, 2022 - Elsevier
Intermittent fasting (IF) has been studied for its effects on lifespan and the prevention or
delay of age-related diseases upon the regulation of metabolic pathways. Mitochondria …

SAMP8 mice as a model of age-related cognition decline with underlying mechanisms in Alzheimer's disease

B Liu, J Liu, JS Shi - Journal of Alzheimer's Disease, 2020 - content.iospress.com
Alzheimer's disease (AD) is a highly age-related cognitive decline frequently attacking the
elderly. Senescence-accelerated mouse-prone 8 (SAMP8) is an ideal model to study AD …

The mitochondrial ATP synthase is a shared drug target for aging and dementia

J Goldberg, A Currais, M Prior, W Fischer, C Chiruta… - Aging cell, 2018 - Wiley Online Library
Aging is a major driving force underlying dementia, such as that caused by Alzheimer's
disease (AD). While the idea of targeting aging as a therapeutic strategy is not new, it …

Discovery and in vivo proof of concept of a highly potent dual inhibitor of soluble epoxide hydrolase and acetylcholinesterase for the treatment of Alzheimer's disease

S Codony, C Pont, C Griñán-Ferré… - Journal of Medicinal …, 2022 - ACS Publications
With innumerable clinical failures of target-specific drug candidates for multifactorial
diseases, such as Alzheimer's disease (AD), which remains inefficiently treated, the advent …

Oxidative stress, cellular senescence and ageing

A Pole, M Dimri, GP Dimri - AIMS molecular science, 2016 - hsrc.himmelfarb.gwu.edu
Almost a half century ago, the free radical theory of ageing proposed that the reactive
oxygen species (ROS) is a key component which contributes to the pathophysiology of …